We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
25 hedge funds and large institutions have $51.9M invested in Fate Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
9% more funds holding
Funds holding: 23 → 25 (+2)
0% more capital invested
Capital invested by funds: $51.7M → $51.9M (+$195K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
10
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$1.46M |
| 2 |
BC
Broadfin Capital
New York
|
+$349K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$182K |
| 4 |
Renaissance Technologies
New York
|
+$73.8K |
| 5 |
SIM
Spark Investment Management
New York
|
+$63.4K |
Top Sellers
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$193K |
| 2 |
Goldman Sachs
New York
|
-$181K |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$153K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$79.4K |
| 5 |
Morgan Stanley
New York
|
-$20K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Morgan Stanley
New York
| – | -$20K | -4,035 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$1K | -200 | Closed |
|